Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Zhejiang, China, 2014-2017

[1]  Jianmin Jiang,et al.  HIV cause-specific deaths, mortality, risk factors, and the combined influence of HAART and late diagnosis in Zhejiang, China, 2006–2013 , 2017, Scientific Reports.

[2]  R. Shafer,et al.  Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis , 2016, PloS one.

[3]  W. Heneine,et al.  Sensitive sentinel mutation screening reveals differential underestimation of transmitted HIV drug resistance among demographic groups , 2016, AIDS.

[4]  T. Musa,et al.  Nationwide Trends in Molecular Epidemiology of HIV-1 in China. , 2016, AIDS research and human retroviruses.

[5]  Bin Zhao,et al.  Increase of RT-Related Transmitted Drug Resistance in Non-CRF01_AE Among HIV Type 1–Infected Men Who Have Sex With Men in the 7 Cities of China , 2015, Journal of acquired immune deficiency syndromes.

[6]  R. Xin,et al.  Trends of subtype variation of human immunodeficiency virus type 1 in Zhejiang Province, China , 2014, Virus Genes.

[7]  W. Guo,et al.  Different Frequencies of Drug Resistance Mutations among HIV-1 Subtypes Circulating in China: A Comprehensive Study , 2014, PloS one.

[8]  Jianqing Xu,et al.  New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk , 2013, PloS one.

[9]  Hsin-Yun Sun,et al.  Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan. , 2012, The Journal of antimicrobial chemotherapy.

[10]  S. Sirivichayakul,et al.  Hiv-1 Drug Resistance Mutations among Antiretroviral-naive Hiv-1– Infected Patients in Asia: Results from the Treat Asia Studies to Evaluate Resistance-monitoring Study on Behalf of the Treat Asia Studies to Evaluate Resistance-monitoring Study (taser-m) , 2022 .

[11]  B. Taiwo.  Understanding transmitted HIV resistance through the experience in the USA. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[12]  S. Hammer,et al.  Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Elizabeth Connick,et al.  Antiretroviral-drug resistance among patients recently infected with HIV. , 2002, The New England journal of medicine.

[14]  J. Kahn,et al.  Time trends in primary HIV-1 drug resistance among recently infected persons. , 2002, JAMA.

[15]  L. Kalish,et al.  Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV Disease , 2001, Annals of Internal Medicine.